Presentation Philip Van Damme
Intracerebroventricular delivery of VEGF is feasible and safe in patients with amyotrophic lateral sclerosis, a phase I study.
Presentation Louis De Muynck
C9orf72 expression in amyotrophic lateral sclerosis and frontotemporal dementia.
Presentation Steven Boeynaems
C9orf72 expansions are potentially pathogenic on three biological levels.
Presentation André Bento-Abreu
ELP3 as a disease modifier in ALS.